Results 101 to 110 of about 748,078 (298)

Utilization of health services among elderly people enrolled in National Health Insurance Program: A cross-sectional study from [PDF]

Balkrishna Tiwari
openalex   +1 more source

Perspectives in educating molecular pathologists on liquid biopsy: Toward integrative, equitable, and decentralized precision oncology

Molecular Oncology, EarlyView.
Liquid biopsy enables minimally invasive, real‐time molecular profiling through analysis of circulating biomarkers in biological fluids. This Perspective highlights the importance of training pathologists through integrative educational programs, such as the European Masters in Molecular Pathology, to ensure effective and equitable implementation of ...
Marius Ilié, Umberto Malapelle, Catherine Alix‐Panabières, Claus Lindbjerg Andersen, Sandra Chlebowski, Vivien Lake, Caroline Lacoux, Virginie Lespinet‐Fabre, Olivier Bordone, Simon Heeke, Christophe Bontoux, Ellen Heitzer, Klaus Pantel, Paul Hofman   +13 more
wiley   +1 more source

Impact of age, HIV1, sickle-cell genotypes, and interferon-gamma gene upstream variants on malaria disease outcomes in a longitudinal pediatric cohort

Scientific Reports
This prospective cohort study explored the association between two upstream IFN-γ variants (rs2069709: G > T and rs2069705: A > G) and hazard factors for malaria outcomes in a longitudinal cohort of children (n = 941, 3–36 mos.), followed for three years.
Evans Raballah, Samuel B. Anyona, Shamim W. Osata, Sharley A. Wasena, Clinton Onyango, Ivy Hurwitz, Qiuying Cheng, Philip D. Seidenberg, Benjamin H. McMahon, Collins Ouma, John M. Ong’echa, Kristan A. Schneider, Douglas J. Perkins   +12 more
doaj   +1 more source

Community health volunteers’ contribution to Tuberculosis patients notified to National Tuberculosis program through contact investigation in Kenya [PDF]

, 2020
Tabitha Abongo, Benson Ulo, Sarah Karanja   +2 more
openalex   +1 more source

Next‐generation proteomics improves lung cancer risk prediction

Molecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj, Clara Frick, Ben Schöttker, Bernd Holleczek, Hermann Brenner   +4 more
wiley   +1 more source

EFFECTIVE IMPLEMENTATION OF NATIONAL HEALTH PROGRAMS: ISSUES AND CHALLENGES

National Journal of Medical Research, 2012
...
Satya Ranjan Lenka, Sitanshu Sekhar Kar   +1 more
doaj  

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

Molecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak, Karolina Pytlak, Sandra Jaworowska, Bogusz Kulawiak, Piotr Bednarczyk   +4 more
wiley   +1 more source

Leadership Development Programs at Academic Health Centers: Results of a National Survey

, 2017
Raymond Lucas, Ellen F. Goldman, Andrea R. Scott, Valerie Dandar   +3 more
openalex   +2 more sources

General Vaccination and Active Prevention of COVID-19 Epidemic at the Primary Health Care Level: The Fifth Step of the National Mobilization Program against COVID-19 [PDF]

, 2022
Alireza Raeisi, Jafar Sadegh Tabrizi, Ardeshir Khosravi, Amin Ataey, Masoumeh Ebrahimi Tavani, Hossein Gholami, A. Azad, Elaheh Koosha, Seyed Hossein Wassegh, Salar Mohammaddokht   +9 more
openalex   +1 more source

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

Molecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute, Júlia Huguet‐Pradell, Jordi Abril‐Fornaguera, Albert Gris‐Oliver, Alex Rialdi, Elisa Fernández‐Martínez, Carla Montironi, Vanessa Del Pozo, Peter Houghton, Laura Zanatto, Agavni Mesropian, Ieva Keraite, Swan Thung, Carolina Armengol, Pau Sancho‐Bru, Ernesto Guccione, Roser Pinyol, Josep M. Llovet   +17 more
wiley   +1 more source